Proton pump inhibitor use and the risk of hepatocellular carcinoma: A systematic review of pharmacoepidemiological data

Ambrish Singh, Benny Antony(University of Tasmania), Robin Jha, Miloslav Klugar(Palacký University Olomouc), Salman Hussain(European CanCer Organisation), Aarthi S Jayraj(All India Institute of Medical Sciences)

Journal of Evidence-Based Medicine

October 13, 2021

10.1111/jebm.12456

Cited by 3

Related Papers

Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

|The Lancet|2021|1.7k

Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021

|The Lancet Rheumatology|2023|1.7k

Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

|The Lancet Rheumatology|2023|632

The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis

|The Lancet Public Health|2022|373

Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

|The Lancet Rheumatology|2023|370